{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T21:13:42Z","timestamp":1779138822951,"version":"3.51.4"},"reference-count":49,"publisher":"Informa UK Limited","issue":"14","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.2217\/pgs-2023-0122","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T08:14:34Z","timestamp":1694765674000},"page":"739-746","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Severe systemic Adverse Reactions to Ophthalmic Timolol in a\n            <i>CYP2D6<\/i>\n            Homozygous\n            <i>*4<\/i>\n            Allele Carrier: A Case Report"],"prefix":"10.1080","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4616-2534","authenticated-orcid":false,"given":"Anna","family":"Bollinger","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Basel, 4056, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1132-0240","authenticated-orcid":false,"given":"Chiara","family":"Jeiziner","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Basel, 4056, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0458-4579","authenticated-orcid":false,"given":"Henriette E","family":"Meyer zu Schwabedissen","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Basel, 4056, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8678-697X","authenticated-orcid":false,"given":"Kurt E","family":"Hersberger","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Basel, 4056, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4067-9401","authenticated-orcid":false,"given":"Samuel S","family":"Allemann","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Basel, 4056, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2437-4803","authenticated-orcid":false,"given":"C\u00e9line K","family":"St\u00e4uble","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Basel, 4056, Basel, Switzerland"},{"name":"Institute of Hospital Pharmacy, Solothurner Spit\u00e4ler AG, 4600, Olten, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61423-7"},{"issue":"13","key":"e_1_3_8_4_1","first-page":"225","article-title":"The diagnosis and treatment of glaucoma","volume":"117","author":"Schuster AK","year":"2020","unstructured":"Schuster AK , ErbC , HoffmannEM , DietleinT , PfeifferN. The diagnosis and treatment of glaucoma. Dtsch. Arztebl. Int.117(13), 225\u2013234 (2020).","journal-title":"Dtsch. Arztebl. Int."},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.11.030"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(03)00003-1"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2007.01.002"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100533"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.13989"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2011.00694.x"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2016.1225718"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1978.03910060433007"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1980.66"},{"key":"e_1_3_8_14_1","unstructured":"Timoptic\u00ae timolol drug label. Santen SA Geneva Switzerland (2022). www.swissmedicinfo.ch\/"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-005-0945-2"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365510601034736"},{"key":"e_1_3_8_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-002-0462-2"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2.5.891"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e31814b990d"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(86)90532-5"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(99)00160-9"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(01)00489-2"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.332.7547.960"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2009.00487.x"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.012906"},{"key":"e_1_3_8_26_1","unstructured":"Annotation of EMA Label for Timolol and CYP2D6 . PharmGKB.. www.pharmgkb.org\/labelAnnotation\/PA166115435 (2019)."},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-6-890"},{"key":"e_1_3_8_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/00912700022008739"},{"key":"e_1_3_8_29_1","unstructured":"Committee for Medical Products for Human Use Pharmacovigilance Working Party of the European Medicines Agency . Monthly report issue no.1106. EMA London UK (2011). www.ema.europa.eu\/en\/documents\/report\/monthly-report-pharmacovigilance-working-party-phvwp-june-2011-plenary-meeting_en.pdf"},{"key":"e_1_3_8_30_1","unstructured":"CYP2D6 \u2013 Drug Label Annotations . PharmGKB (2023). www.pharmgkb.org\/gene\/PA128\/labelAnnotation"},{"key":"e_1_3_8_31_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2017-0033"},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2016.80"},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.1515\/dmpt-2022-0117"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2010.0013"},{"key":"e_1_3_8_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1985.195"},{"key":"e_1_3_8_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530200047035"},{"key":"e_1_3_8_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-005-0052-4"},{"key":"e_1_3_8_38_1","unstructured":"Clinical Annotation for CYP2D6*1 CYP2D6*3 CYP2D6*4 CYP2D6*5; Timolol (Level 3). PharmGKB (2021). www.pharmgkb.org\/clinicalAnnotation\/1183690410"},{"issue":"2","key":"e_1_3_8_39_1","first-page":"203","article-title":"Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure","volume":"43","author":"Brodde OE","year":"1991","unstructured":"Brodde OE . Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol. Rev.43(2), 203\u2013242 (1991).","journal-title":"Pharmacol. Rev."},{"key":"e_1_3_8_40_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.18.2402"},{"key":"e_1_3_8_41_1","unstructured":"Clinical Annotation for rs1801252 (ADRB1); Timolol (Level 3 Efficacy) . PharmGKB. www.pharmgkb.org\/clinicalAnnotation\/1444703187"},{"key":"e_1_3_8_42_1","unstructured":"Clinical Annotation Levels of Evidence . PharmGKB (2023). www.pharmgkb.org\/page\/clinAnnLevels."},{"key":"e_1_3_8_43_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00003.2005"},{"key":"e_1_3_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(03)00087-0"},{"key":"e_1_3_8_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500247"},{"key":"e_1_3_8_46_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.10.88"},{"key":"e_1_3_8_47_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198005010-00004"},{"key":"e_1_3_8_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2005.00562.x"},{"key":"e_1_3_8_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-006-0328-0"},{"key":"e_1_3_8_50_1","unstructured":"Mancia G RoseiEA AziziMet al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur. Heart J.39(33) 3021\u20133104 (2018)."},{"key":"e_1_3_8_51_1","unstructured":"Prioritization of CPIC Guidelines. CPIC (2023). https:\/\/cpicpgx.org\/prioritization-of-cpic-guidelines\/"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pgs-2023-0122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T23:39:59Z","timestamp":1715989199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pgs-2023-0122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":49,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.2217\/pgs-2023-0122"],"URL":"https:\/\/doi.org\/10.2217\/pgs-2023-0122","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-07-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}